Research
Micronutrients & recovery
Curcumin inhibits NF-κB signaling and reduces cancer proliferation in multiple cancer types, including breast, pancreatic, skin, liver, and colon cancer, in mouse models.
Curcumin, found in turmeric, shows promise in reducing cancer risk in animal studies by inhibiting inflammatory pathways. However, its low bioavailability limits its current use as a standalone treatment, and research is focused on improving its absorption.
ModerateSupportsMEDIUM confidence
Experimentally, curcumin has been shown to decrease cancer proliferation in breast and pancreatic cancer cells, as well as to decrease DNA binding of NF-κB, reduce COX-2 protein levels, and inhibit PGE2 production in multiple pancreatic cancer cell lines.
Why this rating
Supported by in vitro and in vivo studies, but human clinical data is less robust.
Source
The growing challenge of obesity and cancer: an inflammatory issue
Alison E. Harvey et al. · Annals of the New York Academy of Sciences · 2011
narrative_reviewCited 269×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →